Veterinary Vaccines Market is Booming 2019 | By Players include Zoetis Inc. Merck Animal Health, Merial Inc., Boehringer Ingelheim, Bayer Animal Health, Elanco Animal Health, Ceva Animal Health, Heska Corporation, Virbac Inc

Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1513665/?utm_source=Openpr&utm_medium=RV

The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.
The global Veterinary Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Veterinary Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Veterinary Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Vaccines in these regions.

This research report categorizes the global Veterinary Vaccines market by top players/brands, region, type and end user. This report also studies the global Veterinary Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac

Market size by Product
Inactivated Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines

Market size by End User
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy

The study objectives of this report are:
To study and analyze the global Veterinary Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Veterinary Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Veterinary Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Veterinary Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Veterinary Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Veterinary Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1513665/?utm_source=Openpr&utm_medium=RV

Table of Contents:
1 Study Coverage
1.1 Veterinary Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Veterinary Vaccines Market Size Growth Rate by Product
1.4.2 Inactivated Vaccines
1.4.3 Live Attenuated Vaccines
1.4.4 Conjugate Vaccines
1.4.5 Toxoid Vaccines
1.4.6 Recombinant Vaccines
1.4.7 DNA Vaccines
1.5 Market by End User
1.5.1 Global Veterinary Vaccines Market Size Growth Rate by End User
1.5.2 Veterinary Clinic
1.5.3 Veterinary Hospital
1.5.4 Veterinary Research Institute
1.5.5 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Veterinary Vaccines Market Size
2.1.1 Global Veterinary Vaccines Revenue 2014-2025
2.1.2 Global Veterinary Vaccines Sales 2014-2025
2.2 Veterinary Vaccines Growth Rate by Regions
2.2.1 Global Veterinary Vaccines Sales by Regions
2.2.2 Global Veterinary Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Veterinary Vaccines Sales by Manufacturers
3.1.1 Veterinary Vaccines Sales by Manufacturers
3.1.2 Veterinary Vaccines Sales Market Share by Manufacturers
3.1.3 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Veterinary Vaccines Revenue by Manufacturers
3.2.1 Veterinary Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Veterinary Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Veterinary Vaccines Price by Manufacturers
3.4 Veterinary Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Veterinary Vaccines Sales by Product
4.2 Global Veterinary Vaccines Revenue by Product
4.3 Veterinary Vaccines Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Veterinary Vaccines Breakdown Data by End User

6 North America
6.1 North America Veterinary Vaccines by Countries
6.1.1 North America Veterinary Vaccines Sales by Countries
6.1.2 North America Veterinary Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Veterinary Vaccines by Product
6.3 North America Veterinary Vaccines by End User

7 Europe
7.1 Europe Veterinary Vaccines by Countries
7.1.1 Europe Veterinary Vaccines Sales by Countries
7.1.2 Europe Veterinary Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary Vaccines by Product
7.3 Europe Veterinary Vaccines by End User

8 Asia Pacific
8.1 Asia Pacific Veterinary Vaccines by Countries
8.1.1 Asia Pacific Veterinary Vaccines Sales by Countries
8.1.2 Asia Pacific Veterinary Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Veterinary Vaccines by Product
8.3 Asia Pacific Veterinary Vaccines by End User

9 Central & South America
9.1 Central & South America Veterinary Vaccines by Countries
9.1.1 Central & South America Veterinary Vaccines Sales by Countries
9.1.2 Central & South America Veterinary Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Veterinary Vaccines by Product
9.3 Central & South America Veterinary Vaccines by End User

10 Middle East and Africa
10.1 Middle East and Africa Veterinary Vaccines by Countries
10.1.1 Middle East and Africa Veterinary Vaccines Sales by Countries
10.1.2 Middle East and Africa Veterinary Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Veterinary Vaccines by Product
10.3 Middle East and Africa Veterinary Vaccines by End User

11 Company Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Company Business Overview
11.1.3 Elanco Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Elanco Veterinary Vaccines Products Offered
11.1.5 Elanco Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Veterinary Vaccines Products Offered
11.2.5 Merck Recent Development
11.3 Merial
11.3.1 Merial Company Details
11.3.2 Company Business Overview
11.3.3 Merial Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merial Veterinary Vaccines Products Offered
11.3.5 Merial Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Details
11.4.2 Company Business Overview
11.4.3 Zoetis Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Zoetis Veterinary Vaccines Products Offered
11.4.5 Zoetis Recent Development
11.5 Advaxis
11.5.1 Advaxis Company Details
11.5.2 Company Business Overview
11.5.3 Advaxis Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Advaxis Veterinary Vaccines Products Offered
11.5.5 Advaxis Recent Development
11.6 AmpliPhi Biosciences
11.6.1 AmpliPhi Biosciences Company Details
11.6.2 Company Business Overview
11.6.3 AmpliPhi Biosciences Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AmpliPhi Biosciences Veterinary Vaccines Products Offered
11.6.5 AmpliPhi Biosciences Recent Development
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Aratana Therapeutics Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Aratana Therapeutics Veterinary Vaccines Products Offered
11.7.5 Aratana Therapeutics Recent Development
11.8 ARKO Labs
11.8.1 ARKO Labs Company Details
11.8.2 Company Business Overview
11.8.3 ARKO Labs Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 ARKO Labs Veterinary Vaccines Products Offered
11.8.5 ARKO Labs Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Business Overview
11.9.3 Bayer Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bayer Veterinary Vaccines Products Offered
11.9.5 Bayer Recent Development
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 CanFel Therapeutics Veterinary Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 CanFel Therapeutics Veterinary Vaccines Products Offered
11.10.5 CanFel Therapeutics Recent Development
11.11 Ceva Animal Health
11.12 Colorado Serum
11.13 Epitopix
11.14 Genus
11.15 Hygieia Biological Laboratories
11.16 ImmuCell
11.17 Nexvet
11.18 Nuovo Biologics
11.19 UBI
11.20 Valneva
11.21 Vetoquinol
11.22 Virbac

12 Future Forecast
12.1 Veterinary Vaccines Market Forecast by Regions
12.1.1 Global Veterinary Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Veterinary Vaccines Revenue Forecast by Regions 2019-2025
12.2 Veterinary Vaccines Market Forecast by Product
12.2.1 Global Veterinary Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Veterinary Vaccines Revenue Forecast by Product 2019-2025
12.3 Veterinary Vaccines Market Forecast by End User
12.4 North America Veterinary Vaccines Forecast
12.5 Europe Veterinary Vaccines Forecast
12.6 Asia Pacific Veterinary Vaccines Forecast
12.7 Central & South America Veterinary Vaccines Forecast
12.8 Middle East and Africa Veterinary Vaccines Forecast

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.